Gene · 6580
Papers3,731
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
441 to 460 of 3,731
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Resistance to Antiangiogenic Therapy in Hepatocellular Carcinoma: From Molecular Mechanisms to Clinical Impact. | Cancers (Basel) | 2022 | 36551730 | PubTator, text mining | PubMed |
| Effect of Photobiomodulation on Atrophic-Erosive Clinical Forms of Oral Lichen Planus: A Systematic Review. | Dent J (Basel) | 2022 | 36547037 | PubTator, text mining | PubMed |
| Pharmacogenetics of chemotherapy treatment response and -toxicities in patients with osteosarcoma: a systematic review. | BMC Cancer | 2022 | 36536332 | PubTator, text mining | PubMed |
| Assessment of the Classification of Age-Related Macular Degeneration Severity from the Northern Ireland Sensory Ageing Study Using a Measure of Dark Adaptation. | Ophthalmol Sci | 2022 | 36531574 | PubTator, text mining | PubMed |
| Serotonin system in the human placenta - the knowns and unknowns. | Front Endocrinol (Lausanne) | 2022 | 36531448 | PubTator, text mining | PubMed |
| Drug-induced liver injury in COVID-19 treatment: Incidence, mechanisms and clinical management. | Front Pharmacol | 2022 | 36518661 | PubTator, text mining | PubMed |
| Photoreceptor Function and Structure in Autosomal Dominant Vitelliform Macular Dystrophy Caused by BEST1 Mutations. | Invest Ophthalmol Vis Sci | 2022 | 36512348 | PubTator, text mining | PubMed |
| Targeting OCT2 with Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neurotoxicity. | Cancer Res Commun | 2022 | 36506732 | PubTator, text mining | PubMed |
| The Rainbow Arching over the Fluorescent Thienoviologen Mesophases. | Nanomaterials (Basel) | 2022 | 36500907 | PubTator, text mining | PubMed |
| TRPML2 Mucolipin Channels Drive the Response of Glioma Stem Cells to Temozolomide and Affect the Overall Survival in Glioblastoma Patients. | Int J Mol Sci | 2022 | 36499683 | PubTator, text mining | PubMed |
| Glutathione Depletion and MicroRNA Dysregulation in Multiple System Atrophy: A Review. | Int J Mol Sci | 2022 | 36499400 | PubTator, text mining | PubMed |
| Metformin in therapeutic applications in human diseases: its mechanism of action and clinical study. | Mol Biomed | 2022 | 36484892 | PubTator, text mining | PubMed |
| Structure of the mitoribosomal small subunit with streptomycin reveals Fe-S clusters and physiological molecules. | Elife | 2022 | 36480258 | PubTator, text mining | PubMed |
| Clinical, genetic, and epidemiological survey of Polish children and adolescents with severe obesity: A study protocol of the Polish-German study project on severe early-onset obesity. | Front Endocrinol (Lausanne) | 2022 | 36479220 | PubTator, text mining | PubMed |
| Discovery and systematic characterization of risk variants and genes for coronary artery disease in over a million participants. | Nat Genet | 2022 | 36474045 | PubTator, text mining | PubMed |
| Increased amisulpride serum concentration in a patient treated with concomitant pregabalin and trazodone: a case report. | Ther Adv Psychopharmacol | 2022 | 36465957 | PubTator, text mining | PubMed |
| Gut microbiota is correlated with gastrointestinal adverse events of metformin in patients with type 2 diabetes. | Front Endocrinol (Lausanne) | 2022 | 36465607 | PubTator, text mining | PubMed |
| SLC22A3 methylation-mediated gene silencing predicts adverse prognosis in acute myeloid leukemia. | Clin Epigenetics | 2022 | 36461046 | PubTator, text mining | PubMed |
| Viral proteases as therapeutic targets. | Mol Aspects Med | 2022 | 36459838 | PubTator, text mining | PubMed |
| TOPAS, a network-based approach to detect disease modules in a top-down fashion. | NAR Genom Bioinform | 2022 | 36458021 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6580/papers?page=23